Rosalind Advisors, Inc. Top Holdings and 13F Report (2025) About Rosalind Advisors, Inc.Investment ActivityRosalind Advisors, Inc. has $210.89 million in total holdings as of June 30, 2025.Rosalind Advisors, Inc. owns shares of 37 different stocks, but just 15 companies or ETFs make up 80% of its holdings.Approximately 19.31% of the portfolio was purchased this quarter.About 18.24% of the portfolio was sold this quarter.This quarter, Rosalind Advisors, Inc. has purchased 34 new stocks and bought additional shares in 7 stocks.Rosalind Advisors, Inc. sold shares of 9 stocks and completely divested from 9 stocks this quarter.Largest Holdings Delcath Systems $33,003,890Adherex Technologies $16,978,845Cytokinetics $13,216,000Ocular Therapeutix $11,309,536IDEAYA Biosciences $10,743,994 Largest New Holdings this Quarter 23282W605 - Cytokinetics $13,216,000 Holding76200L309 - Rezolute $7,765,801 Holding156944100 - CG ONCOLOGY INC $5,017,324 Holding45782T955 - INMUNE BIO INC $1,764,385 HoldingM96088905 - UROGEN PHARMA LTD $600,000 Holding Largest Purchases this Quarter Cytokinetics 400,000 shares (about $13.22M)Rezolute 1,741,211 shares (about $7.77M)CG ONCOLOGY INC 192,974 shares (about $5.02M)Delcath Systems 400,000 shares (about $4M)Adherex Technologies 262,800 shares (about $2.18M) Largest Sales this Quarter Urogen Pharma 407,634 shares (about $5.58M)IDEAYA Biosciences 188,868 shares (about $3.97M)Verastem 600,954 shares (about $2.49M)MediWound 99,832 shares (about $1.93M)Trevi Therapeutics 312,901 shares (about $1.71M) Sector Allocation Over TimeMap of 500 Largest Holdings ofRosalind Advisors, Inc. Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorDCTHDelcath Systems$33,003,890$4,000,000 ▲13.8%3,300,38915.6%MedicalFENCAdherex Technologies$16,978,845$2,181,240 ▲14.7%2,045,6448.1%MedicalCYTKCytokinetics$13,216,000$13,216,000 ▲New Holding400,0006.3%MedicalOCULOcular Therapeutix$11,309,5360.0%1,218,7005.4%MedicalIDYAIDEAYA Biosciences$10,743,994$3,970,005 ▼-27.0%511,1325.1%MedicalXERSXeris Biopharma$10,066,623$1,589,630 ▼-13.6%2,155,5944.8%MedicalVRDNViridian Therapeutics$9,786,000$1,467,900 ▲17.6%700,0004.6%MedicalVRNAVerona Pharma PLC American Depositary Share$9,458,0000.0%100,0004.5%MedicalVSTMVerastem$8,480,786$2,493,959 ▼-22.7%2,043,5634.0%MedicalREPLReplimune Group$8,361,000$464,500 ▲5.9%900,0004.0%MedicalMDWDMediWound$7,884,771$1,933,746 ▼-19.7%407,0613.7%MedicalMYOMyomo$7,766,902$1,926,994 ▲33.0%3,595,7883.7%MedicalRZLTRezolute$7,765,801$7,765,801 ▲New Holding1,741,2113.7%MedicalURGNUrogen Pharma$7,430,414$5,584,586 ▼-42.9%542,3663.5%MedicalCYBIN INC$6,803,6020.0%810,9183.2%COM NEWSVRASavara$6,053,2720.0%2,654,9442.9%MedicalNSPRInspireMD$5,196,254$32,027 ▲0.6%2,289,0992.5%MedicalCG ONCOLOGY INC$5,017,324$5,017,324 ▲New Holding192,9742.4%COMPROFProfound Medical$4,083,8910.0%692,1851.9%MedicalPHVSPharvaris$3,935,8350.0%223,6271.9%MedicalPOLYPID LTD$3,443,380$150,233 ▼-4.2%975,4621.6%COMMNMDMind Medicine (MindMed)$2,725,8000.0%420,0001.3%MedicalKALVKalVista Pharmaceuticals$1,783,081$1,652,101 ▼-48.1%157,7250.8%MedicalINMUNE BIO INC$1,764,385$1,764,385 ▲New Holding1,033,2000.8%PUTTRVITrevi Therapeutics$1,641,000$1,711,568 ▼-51.1%300,0000.8%MedicalCMPSCOMPASS Pathways$1,351,422$953,777 ▼-41.4%482,6510.6%MedicalACRXAcelRx Pharmaceuticals$922,2120.0%2,003,9390.4%MedicalBIOFRONTERA INC$694,742$236,257 ▲51.5%976,4480.3%COM NEWUROGEN PHARMA LTD$600,000$600,000 ▲New Holding100,0000.3%CALLKURAKura Oncology$577,0000.0%100,0000.3%MedicalSPDR SERIES TRUST$534,000$534,000 ▲New Holding550,0000.3%PUTREPLIMUNE GROUP INC$515,650$515,650 ▲New Holding231,8000.2%CALLSPDR S&P 500 ETF TR$432,500$432,500 ▲New Holding250,0000.2%PUTATYR PHARMA INC$271,050$271,050 ▲New Holding223,0000.1%PUTOVIDOvid Therapeutics$164,950$164,950 ▲New Holding500,0000.1%MedicalIDEAYA BIOSCIENCES INC$68,000$68,000 ▲New Holding20,0000.0%CALLCRINETICS PHARMACEUTICALS IN$57,970$57,970 ▲New Holding52,7000.0%CALLABEOAbeona Therapeutics$0$8,595,689 ▼-100.0%00.0%MedicalNUVBNuvation Bio$0$4,314,640 ▼-100.0%00.0%MedicalOPTINOSE INC$0$2,349,262 ▼-100.0%00.0%COM NEWCOGTCogent Biosciences$0$1,487,227 ▼-100.0%00.0%MedicalKIORA PHARMACEUTICALS INC$0$752,678 ▼-100.0%00.0%COMALPHA COGNITION INC$0$530,470 ▼-100.0%00.0%COM NEWINVESCO QQQ TR$0$373,500 ▼-100.0%00.0%PUTLEXICON PHARMACEUTICALS INC$0$30,000 ▼-100.0%00.0%CALLCANDEL THERAPEUTICS INC$0$3,570 ▼-100.0%00.0%PUTShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access